Omalizumab use during pregnancy for CIU: a tertiary care experience. [electronic resource]
Producer: 20170117Description: 145-6 p. digitalISSN:- 1764-1489
- Adult
- Anti-Allergic Agents -- adverse effects
- Chronic Disease
- Female
- Humans
- Immunosuppressive Agents -- adverse effects
- Ohio
- Omalizumab -- adverse effects
- Pregnancy
- Pregnancy Complications -- diagnosis
- Remission Induction
- Risk Assessment
- Tertiary Care Centers
- Treatment Outcome
- Urticaria -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.